Clinical Trial Update: Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating temozolomide with concomitant whole-brain radiotherapy in patients with non-small cell lung cancer and brain metastases. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: NSCLC | Phase 1, Phase 2 | Status: UNKNOWN